Related references
Note: Only part of the references are listed.Standardized Magnetic Resonance Imaging Reporting Using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Criteria and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion with Transperineal Saturation Biopsy to Select Men on Active Surveillance
Svenja Dieffenbacher et al.
EUROPEAN UROLOGY FOCUS (2021)
Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis
Marlon Perera et al.
EUROPEAN UROLOGY (2020)
Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study
Tommy Nyberg et al.
EUROPEAN UROLOGY (2020)
Diagnostic Accuracy of Prostate Biopsy for Detecting Cribriform Gleason Pattern 4 Carcinoma and Intraductal Carcinoma in Paired Radical Prostatectomy Specimens: Implications for Active Surveillance
Kyle J. Ericson et al.
JOURNAL OF UROLOGY (2020)
Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up
Laurence Klotz et al.
EUROPEAN UROLOGY (2020)
Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received
David E. Neal et al.
EUROPEAN UROLOGY (2020)
Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer
Karen E. Hoffman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline
Scott E. Eggener et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
Geert J. L. H. van Leenders et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review
Lisa Moris et al.
EUROPEAN UROLOGY (2020)
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection
Giorgio Gandaglia et al.
EUROPEAN UROLOGY (2020)
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
Michael S. Hofman et al.
LANCET (2020)
Diagnostic Performance of 68Gallium Labelled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging for Staging the Prostate Cancer with Intermediate or High Risk Prior to Radical Prostatectomy: A Systematic Review and Meta-Analysis
Hui Wu et al.
WORLD JOURNAL OF MENS HEALTH (2020)
Adjuvant radiation with androgen-deprivation therapy for men with lymph node metastases after radical prostatectomy: identifying men who benefit
Mohit Gupta et al.
BJU INTERNATIONAL (2019)
Which Patients with Negative Magnetic Resonance Imaging Can Safely Avoid Biopsy for Prostate Cancer?
Masakatsu Oishi et al.
JOURNAL OF UROLOGY (2019)
Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes
Felix Preisser et al.
EUROPEAN UROLOGY (2019)
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
Jonas Hugosson et al.
EUROPEAN UROLOGY (2019)
Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial
Seth A. Rosenthal et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis
Jianjian Xiang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2019)
Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines
Piper Nicolosi et al.
JAMA ONCOLOGY (2019)
Role of Core Number and Location in Targeted Magnetic Resonance Imaging-Ultrasound Fusion Prostate Biopsy
Amanda Jane Lu et al.
EUROPEAN UROLOGY (2019)
Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies
William C. Jackson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients
H. J. Boyle et al.
EUROPEAN JOURNAL OF CANCER (2019)
The primacy of multiparametric MRI in men with suspected prostate cancer
Jonathan Richenberg et al.
EUROPEAN RADIOLOGY (2019)
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
Elizabeth C. Page et al.
EUROPEAN UROLOGY (2019)
A Phase III Multi-Centre Randomised Trial comparing adjuvant versus early salvage Radiotherapy following a Radical Prostatectomy: Results of the TROG 08.03 and ANZUP RAVES Trial
A. Kneebone et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
Anders Widmark et al.
LANCET (2019)
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial
Douglas H. Brand et al.
LANCET ONCOLOGY (2019)
LBA48_PRAdjuvant or salvage radiotherapy for the treatment of localised prostate cancer? A prospectively planned aggregate data meta-analysis
C L Vale et al.
ANNALS OF ONCOLOGY (2019)
The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk Stratification
Sami Humid et al.
EUROPEAN UROLOGY (2019)
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies
Giorgio Gandaglia et al.
EUROPEAN UROLOGY (2019)
Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naive Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study
Marloes van der Leest et al.
EUROPEAN UROLOGY (2019)
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)
Thomas B. L. Lam et al.
EUROPEAN UROLOGY (2019)
Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study
Olivier Rouviere et al.
LANCET ONCOLOGY (2019)
A Systematic Review of the Role of Definitive Local Treatment in Patients with Clinically Lymph Node-positive Prostate Cancer
Eugenio Ventimiglia et al.
EUROPEAN UROLOGY ONCOLOGY (2019)
The Impact of 68Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter Study
Paul J. Roach et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis
Leen Naji et al.
ANNALS OF FAMILY MEDICINE (2018)
Is magnetic resonance imaging-targeted biopsy a useful addition to systematic confirmatory biopsy in men on active surveillance for low-risk prostate cancer? A systematic review and meta-analysis
Ivo G. Schoots et al.
BJU INTERNATIONAL (2018)
Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial
Goran M. Ahlgren et al.
EUROPEAN UROLOGY (2018)
Impact of Adjuvant Radiotherapy in Node-positive Prostate Cancer Patients: The Importance of Patient Selection
Firas Abdollah et al.
EUROPEAN UROLOGY (2018)
Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence Postprostatectomy
Daniel E. Spratt et al.
EUROPEAN UROLOGY (2018)
Focal Therapy in Primary Localised Prostate Cancer: The European Association of Urology Position in 2018
Henk G. van der Poel et al.
EUROPEAN UROLOGY (2018)
Prostate-Specific Antigen-Based Screening for Prostate Cancer Evidence Report and Systematic Review for the US Preventive Services Task Force
Joshua J. Fenton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality The CAP Randomized Clinical Trial
Richard M. Martin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Screening for Prostate Cancer US Preventive Services Task Force Recommendation Statement
David C. Grossman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Randomized Trial of Partial Gland Ablation with Vascular Targeted Phototherapy versus Active Surveillance for Low Risk Prostate Cancer: Extended Followup and Analyses of Effectiveness
Inderbir S. Gill et al.
JOURNAL OF UROLOGY (2018)
Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study
Geoffrey D. Coughlin et al.
LANCET ONCOLOGY (2018)
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
V Kasivisvanathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy
Nina-Sophie Schmidt-Hegemann et al.
RADIATION ONCOLOGY (2018)
68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review
Julia Corfield et al.
WORLD JOURNAL OF UROLOGY (2018)
Chemoprophylaxis during transrectal prostate needle biopsy: critical analysis through randomized clinical trial
Ahmed M. Elshal et al.
WORLD JOURNAL OF UROLOGY (2018)
Impact of a Structured Reporting Template on Adherence to Prostate Imaging Reporting and Data System Version 2 and on the Diagnostic Performance of Prostate MRI for Clinically Significant Prostate Cancer
Hiram Shaish et al.
JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY (2018)
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer The NRG Oncology RTOG 0126 Randomized Clinical Trial
Jeff M. Michalski et al.
JAMA ONCOLOGY (2018)
Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies
Eleanor L. Watts et al.
EUROPEAN UROLOGY (2018)
Prognostic Biomarkers Used for Localised Prostate Cancer Management: A Systematic Review
Pierre-Jean Lamy et al.
EUROPEAN UROLOGY FOCUS (2018)
Optimizing the Number of Cores Targeted During Prostate Magnetic Resonance Imaging Fusion Target Biopsy
Alexander P. Kenigsberg et al.
EUROPEAN UROLOGY ONCOLOGY (2018)
Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naive men with suspicion of prostate cancer
Nienke L. Hansen et al.
BJU INTERNATIONAL (2018)
Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States
Scott P. Kelly et al.
EUROPEAN UROLOGY FOCUS (2018)
Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naive patients
Satoshi Washino et al.
BJU INTERNATIONAL (2017)
Hypofractionated radiotherapy for localized prostate cancer
Stefan Hoecht et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2017)
Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis
Lana Pepdjonovic et al.
WORLD JOURNAL OF UROLOGY (2017)
Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review
Michael Lardas et al.
EUROPEAN UROLOGY (2017)
Sentinel Node Procedure in Prostate Cancer: A Systematic Review to Assess Diagnostic Accuracy
Esther M. K. Wit et al.
EUROPEAN UROLOGY (2017)
The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review
Nicola Fossati et al.
EUROPEAN UROLOGY (2017)
New and Established Technology in Focal Ablation of the Prostate: A Systematic Review
Massimo Valerio et al.
EUROPEAN UROLOGY (2017)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet et al.
EUROPEAN UROLOGY (2017)
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer
W. James Morris et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer
Charles N. Catton et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Redefining and Contextualizing the Hospital Volume-Outcome Relationship for Robot-Assisted Radical Prostatectomy: Implications for Centralization of Care
Boris Gershman et al.
JOURNAL OF UROLOGY (2017)
Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure
Sophie M. Bruinsma et al.
NATURE REVIEWS UROLOGY (2017)
Follow-up of Prostatectomy versus Observation for Early Prostate Cancer
Timothy J. Wilt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Intraductal Carcinoma of the Prostate on Diagnostic Needle Biopsy Predicts Prostate Cancer Mortality: A Population-Based Study
Thorstein Saeter et al.
PROSTATE (2017)
Prostate Biopsy-related Infection: A Systematic Review of Risk Factors, Prevention Strategies, and Management Approaches
Matthew J. Roberts et al.
UROLOGY (2017)
Comparison between transrectal and transperineal prostate biopsy for detection of prostate cancer: a meta-analysis and trial sequential analysis
Jianxin Xue et al.
ONCOTARGET (2017)
Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States
Jim C. Hu et al.
JAMA ONCOLOGY (2017)
Seduction by Sensitivity: Reality, Illusion, or Delusion? The Challenge of Assessing Outcomes after PSMA Imaging Selection of Patients for Treatment
Rodney J. Hicks et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancer
Zachary S. Zumsteg et al.
BJU INTERNATIONAL (2017)
Variability in Outcomes for Patients with Intermediate-risk Prostate Cancer (Gleason Score 7, International Society of Urological Pathology Gleason Group 2-3) and Implications for Risk Stratification: A Systematic Review
Christopher J. Kane et al.
EUROPEAN UROLOGY FOCUS (2017)
Role of MRI in low-risk prostate cancer: finding the wolf in sheep's clothing or the sheep in wolf's clothing?
Ivo G. Schoots et al.
CURRENT OPINION IN UROLOGY (2017)
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Definition of Grading Patterns and Proposal for a New Grading System
Jonathan I. Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 study
F. B. Thomsen et al.
ANNALS OF ONCOLOGY (2016)
Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy
Nicola Fossati et al.
EUROPEAN UROLOGY (2016)
A Critical Analysis of the Current Knowledge of Surgical Anatomy of the Prostate Related to Optimisation of Cancer Control and Preservation of Continence and Erection in Candidates for Radical Prostatectomy: An Update
Jochen Walz et al.
EUROPEAN UROLOGY (2016)
Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis
Maarten de Rooij et al.
EUROPEAN UROLOGY (2016)
PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2
Jeffrey C. Weinreb et al.
EUROPEAN UROLOGY (2016)
Screening for familial and hereditary prostate cancer
Henry T. Lynch et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
High-Dose-Rate Monotherapy for Localized Prostate Cancer: 10-Year Results
Henrik Hauswald et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Cancer Genomics: Diversity and Disparity Across Ethnicity and Geography
Daniel S. W. Tan et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer
W. Robert Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement
Ronald C. Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Can Confirmatory Biopsy be Omitted in Patients with Prostate Cancer Favorable Diagnostic Features on Active Surveillance?
Prassannah Satasivam et al.
JOURNAL OF UROLOGY (2016)
Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience
Hima Bindu Musunuru et al.
JOURNAL OF UROLOGY (2016)
Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial
Luca Incrocci et al.
LANCET ONCOLOGY (2016)
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
David Dearnaley et al.
LANCET ONCOLOGY (2016)
Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy
Charlotte F. Kweldam et al.
MODERN PATHOLOGY (2016)
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
J. L. Donovan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Predictive Factors for Reclassification and Relapse in Prostate Cancer Eligible for Active Surveillance: A Systematic Review and Meta-analysis
Fausto Petrelli et al.
UROLOGY (2016)
Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis
Christopher J. D. Wallis et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis
Christopher J. D. Wallis et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer Data From Patients in the Control Arm of the STAMPEDE Trial
Nicholas D. James et al.
JAMA ONCOLOGY (2016)
Observational studies and the natural history of screen-detected prostate cancer
Peter C. Albertsen
CURRENT OPINION IN UROLOGY (2015)
Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory
Melina Arnold et al.
EUROPEAN JOURNAL OF CANCER (2015)
Active Surveillance for Prostate Cancer: A Systematic Review of Clinicopathologic Variables and Biomarkers for Risk Stratification
Stacy Loeb et al.
EUROPEAN UROLOGY (2015)
Opportunistic Testing Versus Organized Prostate-specific Antigen Screening: Outcome After 18 Years in the Goteborg Randomized Population-based Prostate Cancer Screening Trial
Rebecka Arnsrud Godtman et al.
EUROPEAN UROLOGY (2015)
A Systematic Review of Hypofractionation for Primary Management of Prostate Cancer
Bridget F. Koontz et al.
EUROPEAN UROLOGY (2015)
Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer
Elena Castro et al.
EUROPEAN UROLOGY (2015)
Stratification of High-risk Prostate Cancer into Prognostic Categories: A European Multi-institutional Study
Steven Joniau et al.
EUROPEAN UROLOGY (2015)
Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial
Eva Haglind et al.
EUROPEAN UROLOGY (2015)
Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation
Craig R. Ramsay et al.
HEALTH TECHNOLOGY ASSESSMENT (2015)
Prostate-Specific Antigen Persistence After Radical Prostatectomy as a Predictive Factor of Clinical Relapse-Free Survival and Overall Survival: 10-Year Data of the ARO 96-02 Trial
Thomas Wiegel et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer
Malcolm D. Mason et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Prostate biopsy concordance in a large population-based sample: a Surveillance, Epidemiology and End Results study
David Schreiber et al.
JOURNAL OF CLINICAL PATHOLOGY (2015)
Incidence of Prostate Cancer in Hypogonadal Men Receiving Testosterone Therapy: Observations from 5-Year Median Followup of 3 Registries
Ahmad Haider et al.
JOURNAL OF UROLOGY (2015)
Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial
Karim Fizazi et al.
LANCET ONCOLOGY (2015)
Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement
Laura Van den Bergh et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer
Anusha Kalbasi et al.
JAMA ONCOLOGY (2015)
Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis
K. S. Louie et al.
ANNALS OF ONCOLOGY (2015)
Prostate Cancer Risk Prediction Based on Complete Prostate Cancer Family History
Frederick Albright et al.
PROSTATE (2015)
Comparative Effectiveness of [18F]-Fluorocholine PET-CT and Pelvic MRI With Diffusion-Weighted Imaging for Staging in Patients With High-Risk Prostate Cancer
Jean-Baptiste Pinaquy et al.
PROSTATE (2015)
Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients
Matthias M. Heck et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96-02/AUO AP 09/95 Trial
Thomas Wiegel et al.
EUROPEAN UROLOGY (2014)
Impact of Adjuvant Radiotherapy on Survival of Patients With Node-Positive Prostate Cancer
Firas Abdollah et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Active surveillance for clinically localized prostate cancer--A systematic review
Frederik B. Thomsen et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
Fritz H. Schroder et al.
LANCET (2014)
Meta-analysis of 11C-choline and 18F-choline PET/CT for management of patients with prostate cancer
Finn E. von Eyben et al.
NUCLEAR MEDICINE COMMUNICATIONS (2014)
Long-term results of the Dutch randomized prostate cancer trial: Impact of dose-escalation on local, biochemical, clinical failure, and survival
Wilma D. Heemsbergen et al.
RADIOTHERAPY AND ONCOLOGY (2014)
One-Step TNM Staging of High-Risk Prostate Cancer using Magnetic Resonance Imaging (MRI): Toward an Upfront Simplified all-in-one Imaging Approach?
Vasiliki Pasoglou et al.
PROSTATE (2014)
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis
Guohua Shen et al.
SKELETAL RADIOLOGY (2014)
Clinical outcomes after salvage radiotherapy without androgen deprivation therapy in patients with persistently detectable PSA after radical prostatectomy: results from a national multicentre study
Guillaume Ploussard et al.
WORLD JOURNAL OF UROLOGY (2014)
Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study
Sigrid Carlsson et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Stereotactic Body Radiation Therapy for Low-, Intermediate-, and High-Risk Prostate Cancer: Disease Control and Quality of Life at 6 Years
A. Katz et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Effect of metabolic syndrome and its components on prostate cancer risk: Meta-analysis
K. Esposito et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2013)
Predictive Factors of Oncologic Outcomes in Patients Who do not Achieve Undetectable Prostate Specific Antigen after Radical Prostatectomy
Guillaume Ploussard et al.
JOURNAL OF UROLOGY (2013)
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
Matthew J. Resnick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update
Peter J. Hoskin et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study
Andrew J. Vickers et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group
Peter Grimm et al.
BJU INTERNATIONAL (2012)
Functional Outcomes and Complications Following Radiation Therapy for Prostate Cancer: A Critical Analysis of the Literature
Lars Budaeus et al.
EUROPEAN UROLOGY (2012)
Can Whole-body Magnetic Resonance Imaging with Diffusion-weighted Imaging Replace Tc 99m Bone Scanning and Computed Tomography for Single-step Detection of Metastases in Patients with High-risk Prostate Cancer?
Frederic E. Lecouvet et al.
EUROPEAN UROLOGY (2012)
Systematic Review and Meta-analysis of Studies Reporting Urinary Continence Recovery After Robot-assisted Radical Prostatectomy
Vincenzo Ficarra et al.
EUROPEAN UROLOGY (2012)
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores
Alberto Briganti et al.
EUROPEAN UROLOGY (2012)
Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer
C. Ramsay et al.
HEALTH TECHNOLOGY ASSESSMENT (2012)
The benefits and harms of breast cancer screening: an independent review
M. G. Marmot et al.
LANCET (2012)
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
Michel Bolla et al.
LANCET (2012)
Radical Prostatectomy versus Observation for Localized Prostate Cancer
Timothy J. Wilt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates
Michael Leitzmann et al.
Clinical Epidemiology (2012)
Trends in the treatment of localized prostate cancer using supplemented cancer registry data
Ann S. Hamilton et al.
BJU INTERNATIONAL (2011)
Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy
Jochen Walz et al.
BJU INTERNATIONAL (2011)
Assessing the Impact of Comorbid Illnesses on Death Within 10 Years in Prostate Cancer Treatment Candidates
Patti A. Groome et al.
CANCER (2011)
LONG-TERM FAILURE PATTERNS AND SURVIVAL IN A RANDOMIZED DOSE-ESCALATION TRIAL FOR PROSTATE CANCER. WHO DIES OF DISEASE?
Deborah A. Kuban et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
70 GY VERSUS 80 GY IN LOCALIZED PROSTATE CANCER: 5-YEAR RESULTS OF GETUG 06 RANDOMIZED TRIAL
Veronique Beckendorf et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Gait Speed and Survival in Older Adults
Stephanie Studenski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin/clavulanic acid
Oscar Cuevas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Impact of Comorbidity on Survival Among Men With Localized Prostate Cancer
Peter C. Albertsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer
Christopher U. Jones et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years
Peter Iversen et al.
BJU INTERNATIONAL (2010)
Outcome Predictors of Radical Prostatectomy in Patients With Prostate-Specific Antigen Greater Than 20 ng/ml: A European Multi-Institutional Study of 712 Patients
Martin Spahn et al.
EUROPEAN UROLOGY (2010)
Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09
Anthony L. Zietman et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
Michel Bolla et al.
LANCET ONCOLOGY (2010)
PROSPECTIVE STUDY EVALUATING POSTOPERATIVE RADIOTHERAPY PLUS 2-YEAR ANDROGEN SUPPRESSION FOR POST-RADICAL PROSTATECTOMY PATIENTS WITH PATHOLOGIC T3 DISEASE AND/OR POSITIVE SURGICAL MARGINS
Richard Choo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial
Ian M. Thompson et al.
JOURNAL OF UROLOGY (2009)
Duration of Androgen Suppression in the Treatment of Prostate Cancer
Michel Bolla et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer:: a meta-analysis
A. M. Hovels et al.
CLINICAL RADIOLOGY (2008)
Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy
Ofer Yossepowitch et al.
EUROPEAN UROLOGY (2008)
Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer
Michael J. Zelefsky et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
GRADE:: going from evidence to recommendations
Gordon H. Guyatt et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
A standard procedure for creating a frailty index
Samuel D Searle et al.
BMC Geriatrics (2008)
An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: Updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions
Colleen A. Lawton et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
3-D conformal treatment of prostate cancer to 74 Gy vs. high-dose-rate brachytherapy boost:: A cross-sectional quality-of-life survey
Dirk Vordermark et al.
ACTA ONCOLOGICA (2006)
Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy
Edward M. Messing et al.
LANCET ONCOLOGY (2006)
Relationship of the International Prostate Symptom score with urinary flow studies, and catheterization rates following I-125 prostate brachytherapy
Chandra Martens et al.
BRACHYTHERAPY (2006)
Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma - Long-term results of Phase III RTOG 85-31
MV Pilepich et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomy
CG Rogers et al.
CANCER (2004)
The Mini-Cog as a screen for dementia: Validation in a population-based sample
S Borson et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2003)
Variations in morbidity after radical prostatectomy.
CB Begg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Cancer screening in elderly patients - A framework for individualized decision making
LC Walter et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer
D Ash et al.
RADIOTHERAPY AND ONCOLOGY (2000)
Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study
M Aron et al.
BJU INTERNATIONAL (2000)
Share Paper
